Planet Briefing

First published · Last updated

ALBI-6 – Ein neuer prognostischer Score aus ALBI und Interleukin-6 bei Patient*innen mit hepatozellulärem Karzinom unter Atezolizumab und Bevacizumab

Journal article announcing a new prognostic score (ALBI-6) combining ALBI and interleukin-6 for patients with hepatocellular carcinoma treated with atezolizumab and bevacizumab. The supplied source data did not include further study details, results, or locations.

Categories: public-health, science-and-space

Generated scores

Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.

Confidence
2/10
Geographic reach
1/10
Global importance
2/10
Impact magnitude
2/10
Positivity
6/10
Urgency
1/10

Why it matters

The article presents a new prognostic score for a specific cancer treatment population.

Sources

Report an issue